Exact FDA event identifier

Event 73626

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: March 25, 2016
Product types: Drug
Classifications: Class I
Statuses: Terminated
Recalling firm wording: B. Braun Medical Inc

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

5% Dextrose Injection USP, 100mL in a 150 mL PAB container, Rx only, B. Braun Medical Inc. Irvine, CA 92614-5895 USA, NDC 00264-1510-32

D-0094-2017

Recall number: D-0094-2017
Initiated: March 25, 2016
Classification: Class I
Status: Terminated
Recalling firm: B. Braun Medical Inc
Quantity: 57,408 units

App-derived interpretation

Microbial contamination reason.microbial_contamination · v1.0.0

fungal contamination

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Non-Sterility: fungal contamination due to leaking containers.

Code information

Lot #: J5J706, Exp. 10/31/2016

Distribution pattern

Nationwide